WALTHAM, Mass., Aug. 20 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. announced today that certain executive officers, including Marijn E. Dekkers, president and chief executive officer, are adopting stock- trading programs under Securities and Exchange Commission (SEC) Rule 10b5-1 covering the future sale of company stock. Mr. Dekkers, who exercised options for and sold 300,000 shares over August 15-17, 2007, has adopted a plan for the future sale of up to an additional 780,000 shares, which he would acquire upon the exercise of stock options granted in 2002. Mr. Dekkers entered into this program in order to diversify his financial holdings, although he will continue to have a significant ownership interest in the company. After selling these shares, Mr. Dekkers would own shares, or share equivalents, and hold options totaling 1,860,378 shares.
These trading programs are based on SEC Rule 10b5-1, which protects company executives from possible claims of insider trading by permitting them to buy or sell a predetermined amount of their company’s shares, as set forth in a planned acquisition or divestiture program that was adopted when the insider did not possess any material non-public information.
About Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com .
Media Contact Information: Investor Contact Information: Lori Gorski Ken Apicerno Phone: 781-622-1242 Phone: 781-622-1111 E-mail: lori.gorski@thermofisher.com E-mail: ken.apicerno@thermofisher.com Website: http://www.thermofisher.com
Thermo Fisher Scientific Inc.
CONTACT: Media: Lori Gorski, +1-781-622-1242,lori.gorski@thermofisher.com, or Investors: Ken Apicerno, +1-781-622-1111,ken.apicerno@thermofisher.com, both of Thermo Fisher Scientific Inc.
Web site: http://www.thermofisher.com/
Company News On-Call: http://www.prnewswire.com/comp/877850.html /
